Skip to content

Comparative Study on the Effect of 2 herbal tablets in diabetic patients

Comparative Study of Kampillakadi Ghanvati and Madhumehari Ghanvati in the Management of Kaphapittaja Prameha with Special Reference to Type 2 Diabetes Mellitus - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089729
Enrollment
60
Registered
2025-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

National Institute of Ayurveda, jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed patients of kaphapittaja prameha on the basis of presence of classical signs and symptoms Patients of either sex in the age group of above 18 years and below 70 years. HbA1c is between 5.7% -12%.

Exclusion criteria

Exclusion criteria: Patient having vatolvana/ vataja prameha/ Diabetes mellitus Type-1[IDDM]. Patients with other metabolic and endocrine disorders or any other serious illness Patients with diabetic wounds / ulcers. Patients having chronic complications of Type 2 Diabetes or other chronic debilitating disease like STD etc. Pregnant and lactating women. Patient undergoing any other treatment for diabetes.

Design outcomes

Primary

MeasureTime frame
Change in sign and symptoms of kaphapittaja pramehaand HbA1cTimepoint: after 3 months

Secondary

MeasureTime frame
change in lipid profileTimepoint: after 3 months

Countries

India

Contacts

Public ContactDr Lalchand

National Institute of Ayurveda

bhatnagarshailza@gmail.com09982942244

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026